Cargando…
Inhibiting breast cancer by targeting the thromboxane A(2) pathway
Targeting the estrogen receptor as a strategy has been the gold standard for breast cancer chemoprevention or breast cancer recurrence, but its benefit is limited to estrogen receptor-positive tumors. Cyclooxygenases have been implicated in mammary tumorigenesis. We sought to identify the key prosta...
Autores principales: | Li, Haitao, Lee, Mee-Hyun, Liu, Kangdong, Wang, Ting, Song, Mengqiu, Han, Yaping, Yao, Ke, Xie, Hua, Zhu, Feng, Grossmann, Michael, Cleary, Margot P., Chen, Wei, Bode, Ann M., Dong, Zigang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859468/ https://www.ncbi.nlm.nih.gov/pubmed/29872696 http://dx.doi.org/10.1038/s41698-017-0011-4 |
Ejemplares similares
-
(S)-10-Hydroxycamptothecin Inhibits Esophageal Squamous Cell Carcinoma Growth In Vitro and In Vivo Via Decreasing Topoisomerase I Enzyme Activity
por: Song, Mengqiu, et al.
Publicado: (2019) -
Targeted therapy of the AKT kinase inhibits esophageal squamous cell carcinoma growth in vitro and in vivo
por: Liu, Xuejiao, et al.
Publicado: (2019) -
Targeting LIMK1 with luteolin inhibits the growth of lung cancer in vitro and in vivo
por: Zhang, Man, et al.
Publicado: (2021) -
Targeting ornithine decarboxylase (ODC) inhibits esophageal squamous cell carcinoma progression
por: He, Wei, et al.
Publicado: (2017) -
Targeting the COX1/2-Driven thromboxane A2 pathway suppresses Barrett's esophagus and esophageal adenocarcinoma development
por: Zhang, Tianshun, et al.
Publicado: (2019)